the aid library

LIST OPTIONS

Filter

2407

Disease Control Priorities 3: Palliative Care and Pain Control

World Bank (2018) C1

Palliative care has been shown to provide significant and diverse benefits for patients with serious, complex,or life-limiting health problem. Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R., editors. Disease Control Prio... more

Download (805)

View PDF (2052)

Images showing individual symptoms of Ebola: Muscle Pain

Centers for Disease Control and Prevention CDC (2014)

Download (762)

View PDF (2109)

Images showing individual symptoms of Ebola: Stomach Pain

Centers for Disease Control and Prevention CDC (2014)

Download (123)

View PDF (190)

Implementing the SAFE Strategy for Trachoma Control

Center for Disease Control and Prevention CDC (2006) CC

Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes. This is photomicrograph ... more

WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended

World Health Organization WHO (2024) C_WHO

Human strongyloidiasis is a chronic parasitic disease caused by infection with Strongyloides stercoralis, a soil-transmitted helminth that is estimated to infect 300–600 million people worldwide. This neglected tropical disease (NTD) is endemic globally, predominately in the South-East Asia, Afric... more

External Link

Parasites - Guinea Worm

Center for Disease Control and Prevention CDC (2003) CC

People with Guinea worm disease (GWD) have no symptoms for about 1 year. Then, the person begins to feel ill. Symptoms can include the following: Slight fever Itchy rash Nausea Vomiting Diarrhea Dizziness A blister then develops. This blister can form anywhere on the skin. However, the blis... more

National Monkeypox Public Health Response Guidelines

Federal Ministry of Health - Nigeria Centre for Disease Control (2019) CC

Since the re-emergence of monkeypox in Nigeria in September 2017, the Nigeria Centre for Disease Control(NCDC) has continued to receive reports and respond to cases of the disease from States across the country. Between September 2017 when the out... more

Download (144)

View PDF (193)

Children’s Palliative Care and Human Rights

Open Society Foundation (2015) C1

Palliative care for children with life-limiting illness is the active total care of the child’s body, mind, and spirit. It begins at diagnosis and continues regardless of whether the child receives treatment directed at the disease. It seeks to control... more

External Link

Chikungunya virus: A general overview

Galán-Huerta K.A., Rivas-Estilla A.M., Fernández-Salas I. et al (2015) C2

Chikungunya virus (CHIKV) is a re-emerging mosquito borne alphavirus responsible for the recent outbreak in the Americas. Immunologically naïve population in the Americas favors the spread of epidemics. Chikungunya fever is characterized by an abrupt febrile illness, polyarthralgia and maculopapul... more

Download (410)

View PDF (665)

WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents
recommended

World Health Organization WHO (2019) C_WHO

The aims of these guidelines are to provide guidance to health-care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer. They also assist policy-mak... more

Download (955)

View PDF (2167)

Kenya national palliative care guidelines
recommended

Republic of Kenya, Ministry of Health (2013) C1

Asthma and pregnancy

National Asthma Education Programme (2012) CC2

Asthma can be a serious disease, but if you understand the disease and take the right medication to control it, you should have no problems or symptoms due to your asthma, even when you are pregnant. To be free from asthma attacks, you should al... more

Guidelines for the management of asthma in adults and adolescents: Position statement of the South African Thoracic Society – 2021 update

Lalloo, U.G.; Kalla, I.S.; Abdool-Gaffar, S. et al. African Journal of Thoracic and Critical Care Medicine (2021) CC

sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapte... more

Download (235)

View PDF (519)

COLERA: INFORMAÇA O PARA PROMOTORES DE SAUDE ou ACTIVISTAS

World Health Organisation (WHO) (2019) C2

The PDF "COLERA: Informação para Promotores de Saúde" provides essential guidance for health promoters and activists on cholera. It explains that cholera is characterized by severe watery diarrhea, often resembling rice water, and sometimes vomiting. If not treated promptly, it can lead to death ... more

Download (290)

View PDF (386)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (2924)

View PDF (3287)

Infection Control in Screening Ebola Suspected Cases and Contacts in Health Facility Entry Clinics

Ministry of Health, Uganda; World Health Organization (WHO) (2014)

Accessed June 16,2014

Download (777)

View PDF (1415)

Guidelines For The Control Of Epidemics Due To Shigella Dysenteriae Type 1

World Health Organization (1995)

Download (2250)

View PDF (1788)

Infection control guidelines for managemente of suspected or confirmed Ebola Virus Disease (EVD)

Ministry of Health Saudi Arabia (2014)

The Ministry of Health of Saudi Arabia has developed the guidelines to meet the urgent need for up -to-date information and evidence-based recommendations

External Link

Dengue and Chikungunya Vector Control Pocket Guide

Armed Forces Pest Management Board, USA (2014) CC

Armed Forces Pest Management Board Technical Guide No. 47

Sierra Leone National Infection Prevention and Control Guidelines_2022
recommended

Ministry of Health and Sanitation Sierra Leone, (2022) C1

The Sierra Leone National Infection Prevention and Control Guidelines were jointly developed and updated by the Ministry of Health and Sanitation in collaboration with the World Health Organization and the US Centers for Disease ... and Prevention. more

WHO guideline on preventive chemotherapy for public health control of strongyloidiasis ﻿ recommended

WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents recommended

Kenya national palliative care guidelines recommended

Sierra Leone National Infection Prevention and Control Guidelines_2022 recommended

WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended

WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents
recommended

Kenya national palliative care guidelines
recommended

Sierra Leone National Infection Prevention and Control Guidelines_2022
recommended